Apexigen, Inc. Quarterly Common Stock, Shares Authorized from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Apexigen, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2020 to Q2 2023.
  • Apexigen, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2023 was 1B shares, a 3900% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 1B +975M +3900% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 1B +975M +3900% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1B +976M +4144% Dec 31, 2022 10-Q 2023-08-10
Q3 2022 1B +975M +3900% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 25M 0 0% Jun 30, 2022 10-Q 2022-08-18
Q1 2022 25M 0 0% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 23.6M -1.44M -5.75% Dec 31, 2021 10-K 2023-02-22
Q3 2021 25M Sep 30, 2021 10-Q 2021-12-09
Q2 2021 25M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 25M Mar 31, 2021 10-Q 2021-06-07
Q4 2020 25M Dec 31, 2020 10-K 2022-04-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.